These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 23846930

  • 1. Biomarkers in neuroendocrine tumors.
    Duque M, Modlin IM, Gupta A, Saif MW.
    JOP; 2013 Jul 10; 14(4):372-6. PubMed ID: 23846930
    [Abstract] [Full Text] [Related]

  • 2. Update on novel therapies for pancreatic neuroendocrine tumors.
    Oberstein PE, Saif MW.
    JOP; 2012 Jul 10; 13(4):372-5. PubMed ID: 22797392
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.
    Brauer MJ, Zhuang G, Schmidt M, Yao J, Wu X, Kaminker JS, Jurinka SS, Kolumam G, Chung AS, Jubb A, Modrusan Z, Ozawa T, James CD, Phillips H, Haley B, Tam RN, Clermont AC, Cheng JH, Yang SX, Swain SM, Chen D, Scherer SJ, Koeppen H, Yeh RF, Yue P, Stephan JP, Hegde P, Ferrara N, Singh M, Bais C.
    Clin Cancer Res; 2013 Jul 01; 19(13):3681-92. PubMed ID: 23685835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
    Singh S, Law C.
    Expert Rev Gastroenterol Hepatol; 2012 Jun 01; 6(3):313-34. PubMed ID: 22646254
    [Abstract] [Full Text] [Related]

  • 11. Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy.
    Franco M, Pàez-Ribes M, Cortez E, Casanovas O, Pietras K.
    Horm Metab Res; 2011 Nov 01; 43(12):884-9. PubMed ID: 21960459
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biomarkers in pancreatic adenocarcinoma.
    Joza N, Saif MW.
    JOP; 2014 Jul 28; 15(4):308-9. PubMed ID: 25076328
    [Abstract] [Full Text] [Related]

  • 18. Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.
    Gloesenkamp C, Nitzsche B, Lim AR, Normant E, Vosburgh E, Schrader M, Ocker M, Scherübl H, Höpfner M.
    Int J Oncol; 2012 May 28; 40(5):1659-67. PubMed ID: 22246317
    [Abstract] [Full Text] [Related]

  • 19. Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors.
    Gilbert JA, Adhikari LJ, Lloyd RV, Rubin J, Haluska P, Carboni JM, Gottardis MM, Ames MM.
    Endocr Relat Cancer; 2010 Sep 28; 17(3):623-36. PubMed ID: 20385747
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-1 increases intracellular calcium concentration in human primary neuroendocrine pancreatic tumor cells and a pancreatic neuroendocrine tumor cell line (BON-1) via R-type Ca2+ channels and regulates chromogranin a secretion in BON-1 cells.
    Mergler S, Strauss O, Strowski M, Prada J, Drost A, Langrehr J, Neuhaus P, Wiedenmann B, Ploeckinger U.
    Neuroendocrinology; 2005 Sep 28; 82(2):87-102. PubMed ID: 16424676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.